OVERVIEW

Join us for an event that unites community-based providers and academic oncologists, all dedicated to enhancing the care and outcomes of patients with hematologic malignancies. This activity will explore the latest treatment options and medical advancements aimed at reducing cancer-related deaths. You’ll gain insights into groundbreaking therapies like CAR T-cell therapy, novel immunotherapies, and targeted agents that represent the forefront of managing both newly diagnosed and relapsed blood cancers. Stay informed with the latest scientific updates and innovative strategies that directly impact your practice. Participants will engage in discussions about rapidly evolving treatment landscapes, evaluate critical considerations for sequencing novel agents, and refine practice paradigms that elevate patient care across all treatment settings. This is your chance to enhance your knowledge of best practices for treating hematologic cancers while learning when to refer patients for specialized quaternary care and clinical trial opportunities. Don’t miss out on this chance to stay ahead in your field—register today to secure your spot and transform your approach to patient management!

KEY DATES

Event Start Date
29 Jan, 2027
Event Start Date
Event End Date
29 Jan, 2027
Event End Date
Credits

The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™.

Participants who successfully complete the entire activity and complete an evaluation form will earn 6.75 contact hours. Other participants will receive a Certificate of Participation.

AMA PRA Category 1: Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Contact Hours: University of Chicago Medicine is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.

  • 6.75 AMA PRA Category 1
  • 6.75 Contact Hours
  • 6.75 MOC
  • TARGET AUDIENCE

    Medical OncologistsPathologistsPhysicianPhysician AssistantNurse PractitionerFellows

    SPECIALITIES

    HematologyOncologyInternal Medicine

    SUGGESTED HOTELS

    CONFERENCE VENUE

    LocationSwissotel Chicago
    323 E Upper Wacker Dr

    RELATED CONFERENCES & LIVE WEBINARS